Myasthenia gravis (MG) is a chronic, fluctuating, antibody-mediated autoimmune disorder
directed against the post-synaptic neuromuscular junctions of skeletal muscles, resulting in …

Autoantibodies are frequently observed in healthy individuals. In a minority of these
individuals, they lead to manifestation of autoimmune diseases, such as rheumatoid arthritis …

Neuromuscular junction (NMJ) disorders include several dysfunctions that ultimately lead to
muscle weakness. Myasthenia gravis (MG) is the most prevalent NMJ disorder with a highly …

Background The epidemiology of paraneoplastic neurological syndromes (PNS) remains to
be defined. We present here the first population-based incidence study and report the …

Autoimmune neuromuscular junction disorders are rare. However, myasthenia gravis is
being increasingly recognised in people older than 50 years. In the past 5–10 years …

PURPOSE OF REVIEW Myasthenia gravis (MG) is an autoimmune neuromuscular disease
that causes fluctuating weakness in ocular, bulbar, and limb muscles and can, in 15% of …

When the diagnosis of myasthenia gravis (MG) has been secured, the aim of management
should be prompt symptom control and the induction of remission or minimal manifestations …

Background In the UK, large-scale electronic primary care datasets can provide up-to-date,
accurate epidemiological information on rarer diseases, where specialist diagnoses from …

Importance There are limited data regarding COVID-19 outcomes and vaccine uptake and
safety among people with myasthenia gravis (MG). Objective To investigate COVID-19 …

Background Myasthenia gravis is a neuromuscular autoimmune disorder characterized by
weakness and disability in the voluntary muscles. There have been several preliminary …